|Min SIP Amount||₹1000|
|NAV||₹17.27 (23 Oct 2020)|
|Fund Started||02 Jul 2018|
|Fund Size||₹1,006 Cr|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||11.3%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||9.8%|
|Divi's Laboratories Ltd.||Healthcare||Equity||8.0%|
|Ipca Laboratories Ltd.||Healthcare||Equity||6.1%|
|Torrent Pharmaceuticals Ltd.||Healthcare||Equity||5.0%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||4.8%|
|Laurus Labs Ltd.||Healthcare||Equity||4.4%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||4.0%|
Mirae Asset Healthcare Fund Regular Growth is a Equity Mutual Fund Scheme launched by Mirae Asset Mutual Fund. This scheme was made available to investors on 02 Jul 2018. Vrijesh Kasera is the Current Fund Manager of Mirae Asset Healthcare Fund Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,006 Cr and the Latest NAV as of 23 Oct 2020 is ₹17.27.
The Mirae Asset Healthcare Fund Regular Growth is rated High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 year.
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.